GDRX

3.39

1.19% 0.04

Dopo l'orario di chiusura: 3.33 -0.06 -1.77%

Goodrx Holdings Inc (GDRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GDRX Giù? Forum Previsione

Precedente Chiudi:

$3.35

Aprire:

$3.39

Volume 24 ore:

491.85K

Relative Volume:

0.36

Capitalizzazione di mercato:

$1.16B

Reddito:

$787.89M

Utile/perdita netta:

$20.56M

Rapporto P/E:

57.95

EPS:

0.0585

Flusso di cassa netto:

$96.54M

1 W Prestazione:

-2.59%

1M Prestazione:

-10.79%

6M Prestazione:

+50.67%

1 anno Prestazione:

-19.67%

Intervallo 1D:

$3.325

$3.4198

Intervallo di 1 settimana:

$3.28

$3.545

Portata 52W:

$1.77

$5.8099

Goodrx Holdings Inc Stock (GDRX) Company Profile

Nome

Goodrx Holdings Inc

Settore

Healthcare (1069)

Industria

Health Information Services (47)

Telefono

(855) 268-2822

Indirizzo

2701 OLYMPIC BOULEVARD, SANTA MONICA

Dipendente

697

Cinguettio

Prossima data di guadagno

2026-11-03

Ultimi documenti SEC

GDRX's Discussions on Twitter

Compare GDRX vs VEEV, BTSG, TEM, TXG, HQY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GDRX Goodrx Holdings Inc	3.39	1.14B	787.89M	20.56M	96.54M	0.0585
VEEV Veeva Systems Inc	262.40	42.25B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	58.73	11.45B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	59.01	10.66B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	68.59	8.65B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	96.26	7.82B	1.34B	230.70M	440.96M	2.6695

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-27	Downgrade	JP Morgan	Overweight → Neutral
2026-01-22	Downgrade	Jefferies	Buy → Hold
2025-12-09	Iniziato	Barclays	Underweight
2025-08-11	Downgrade	Raymond James	Strong Buy → Outperform
2024-12-04	Iniziato	Mizuho	Neutral
2024-08-09	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-05-23	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2024-05-16	Aggiornamento	Raymond James	Mkt Perform → Outperform
2024-04-10	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2024-03-25	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-03-01	Aggiornamento	JP Morgan	Neutral → Overweight
2024-02-26	Iniziato	Leerink Partners	Outperform
2024-01-02	Downgrade	BofA Securities	Buy → Underperform
2023-08-10	Aggiornamento	DA Davidson	Neutral → Buy
2023-07-31	Aggiornamento	TD Cowen	Market Perform → Outperform
2022-12-01	Iniziato	Citigroup	Buy
2022-11-04	Aggiornamento	JP Morgan	Underweight → Neutral
2022-09-16	Iniziato	KeyBanc Capital Markets	Sector Weight
2022-09-07	Iniziato	Truist	Hold
2022-08-12	Iniziato	DA Davidson	Neutral
2022-06-10	Downgrade	Goldman	Buy → Neutral
2022-06-06	Ripresa	BofA Securities	Buy
2022-06-01	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-10	Downgrade	Evercore ISI	Outperform → In-line
2022-05-10	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-05-10	Downgrade	Raymond James	Outperform → Mkt Perform
2022-05-10	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-04-11	Iniziato	Wells Fargo	Equal Weight
2022-04-07	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Neutral
2022-03-15	Aggiornamento	Robert W. Baird	Neutral → Outperform
2022-03-01	Reiterato	Barclays	Overweight
2022-03-01	Reiterato	BofA Securities	Neutral
2022-03-01	Downgrade	Cowen	Outperform → Market Perform
2022-03-01	Downgrade	Credit Suisse	Outperform → Neutral
2022-03-01	Reiterato	Evercore ISI	Outperform
2022-03-01	Reiterato	Goldman	Buy
2022-03-01	Reiterato	JP Morgan	Underweight
2022-03-01	Reiterato	RBC Capital Mkts	Outperform
2022-03-01	Reiterato	SVB Leerink	Outperform
2022-01-07	Iniziato	Goldman	Buy
2021-12-21	Iniziato	Stephens	Overweight
2021-12-02	Iniziato	Jefferies	Buy
2021-08-31	Aggiornamento	Barclays	Equal Weight → Overweight
2021-08-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-05-28	Iniziato	Robert W. Baird	Neutral
2021-04-06	Ripresa	Evercore ISI	Outperform
2021-01-25	Iniziato	Guggenheim	Buy
2020-11-19	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2020-11-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-10-19	Iniziato	Barclays	Equal Weight
2020-10-19	Iniziato	BofA Securities	Neutral
2020-10-19	Iniziato	Citigroup	Buy
2020-10-19	Iniziato	Cowen	Outperform
2020-10-19	Iniziato	Credit Suisse	Outperform
2020-10-19	Iniziato	Deutsche Bank	Hold
2020-10-19	Iniziato	Goldman	Neutral
2020-10-19	Iniziato	JP Morgan	Neutral
2020-10-19	Iniziato	Morgan Stanley	Overweight
2020-10-19	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-19	Iniziato	SVB Leerink	Outperform
2020-10-19	Iniziato	UBS	Buy

Mostra tutto

Goodrx Holdings Inc Borsa (GDRX) Ultime notizie

Sep 09, 2026

GoodRX’s $32 Million Data-Sharing Settlement Wins Initial Nod - Bloomberg Law News

Sep 09, 2026

Sep 06, 2026

InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - Investing.com Australia

Sep 06, 2026

Sep 03, 2026

GoodRx offers health subscription for families, to launch as employee benefit in 2027 - reuters.com

Sep 03, 2026

GDRX Looks 34.8% Undervalued on GF Value™ - GuruFocus

Sep 03, 2026

One plan covers kids, adults and pets. GoodRx's new membership costs $24.99 a month. - Stock Titan

Sep 03, 2026

Aug 31, 2026

Promising Penny Stocks To Consider In August 2026 - simplywall.st

Aug 31, 2026

Aug 27, 2026

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX) - The Globe and Mail

Aug 27, 2026

GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com Nigeria

Aug 27, 2026

Aug 26, 2026

Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale - Stock Titan

Aug 26, 2026

Aug 24, 2026

GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Moomoo

Aug 24, 2026

Aug 23, 2026

GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingROE Trend Analysis - vinanet.vn

Aug 23, 2026

Aug 21, 2026

Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat

Aug 19, 2026

Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn

Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move: Shares Move Lower 1.88% in Latest TradingShare Repurchase Impact - siam.in

Aug 18, 2026

Aug 17, 2026